PT941095E - Composicoes farmaceuticas melhoradas - Google Patents

Composicoes farmaceuticas melhoradas

Info

Publication number
PT941095E
PT941095E PT97948461T PT97948461T PT941095E PT 941095 E PT941095 E PT 941095E PT 97948461 T PT97948461 T PT 97948461T PT 97948461 T PT97948461 T PT 97948461T PT 941095 E PT941095 E PT 941095E
Authority
PT
Portugal
Prior art keywords
improved
pharmaceutical compositions
improved pharmaceutical
resuspendability
suspensions
Prior art date
Application number
PT97948461T
Other languages
English (en)
Inventor
Todd P Foster
David L Kiefer
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25194373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT941095(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PT941095E publication Critical patent/PT941095E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
PT97948461T 1996-12-09 1997-12-03 Composicoes farmaceuticas melhoradas PT941095E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/806,584 US5736151A (en) 1996-12-09 1996-12-09 Antibiotic oil suspensions

Publications (1)

Publication Number Publication Date
PT941095E true PT941095E (pt) 2004-08-31

Family

ID=25194373

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97948461T PT941095E (pt) 1996-12-09 1997-12-03 Composicoes farmaceuticas melhoradas

Country Status (22)

Country Link
US (1) US5736151A (pt)
EP (1) EP0941095B1 (pt)
JP (1) JP2001505910A (pt)
KR (1) KR100544248B1 (pt)
CN (1) CN100413506C (pt)
AT (1) ATE264681T1 (pt)
AU (1) AU746666B2 (pt)
BR (1) BR9714967B1 (pt)
CA (1) CA2269682C (pt)
CZ (1) CZ297632B6 (pt)
DE (1) DE69728783T2 (pt)
DK (1) DK0941095T3 (pt)
ES (1) ES2218705T3 (pt)
FI (1) FI991302A (pt)
HK (1) HK1023292A1 (pt)
HU (1) HUP0000564A3 (pt)
NO (1) NO325475B1 (pt)
NZ (1) NZ336183A (pt)
PL (1) PL190662B1 (pt)
PT (1) PT941095E (pt)
SK (1) SK72399A3 (pt)
WO (1) WO1998025621A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524694A (en) * 2000-09-12 2005-05-27 Upjohn Co Pharmaceutical composition having modified carrier
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
AU2002328168B2 (en) * 2002-08-07 2008-08-21 Merial Ltd. Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
RU2325189C2 (ru) * 2003-03-20 2008-05-27 Фармация Корпорейшн Способ и фармацевтическая композиция для доставки противовоспалительного средства
CA2529405A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
ES2423929T3 (es) * 2007-02-16 2013-09-25 Aska Pharmaceutical Co., Ltd. Composición farmacéutica que contiene suspensión basada en aceite de partículas finas
CN101406447B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方头孢噻呋油混悬注射液制备工艺
US20100087481A1 (en) * 2008-10-03 2010-04-08 Lee Kathleen M Oral pharmaceutical formulations for antidiabetic compounds
CA2743551C (en) * 2008-11-19 2017-08-15 Merial Limited Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
MX358248B (es) 2012-07-17 2018-08-10 Bayer New Zealand Ltd Formulaciones antibioticas inyectables que contienen penetamato y triacetina.
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
CN106456704A (zh) 2014-04-16 2017-02-22 Veyx-药物有限公司 兽药组合物和其应用
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
US10420776B2 (en) * 2016-10-13 2019-09-24 RhinoNase, Inc. Antibiotic compositions for nasal irrigation and methods
CA3058806A1 (en) 2017-04-03 2018-10-11 Coherus Biosciences Inc. Ppar.gamma. agonist for treatment of progressive supranuclear palsy
CN113209015A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效盐酸头孢噻呋混悬注射液及其制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
NL260648A (pt) * 1961-01-31
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
US4937330A (en) * 1985-08-12 1990-06-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
US5223496A (en) * 1987-11-10 1993-06-29 The Upjohn Company Cephalosporin antibiotics
AU617377B2 (en) * 1987-11-10 1991-11-28 Pharmacia & Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes
KR920702616A (ko) * 1989-06-13 1992-10-06 원본미기재 약제를 전달하기 위한 무수 오일-기제된 액체 현탁액
CN1055090C (zh) * 1993-03-12 2000-08-02 法玛西雅厄普约翰美国公司 结晶性头孢噻夫游离酸

Also Published As

Publication number Publication date
ATE264681T1 (de) 2004-05-15
NO992780L (no) 1999-06-08
AU746666B2 (en) 2002-05-02
FI991302A0 (fi) 1999-06-08
ES2218705T3 (es) 2004-11-16
FI991302A (fi) 1999-06-08
CN100413506C (zh) 2008-08-27
HK1023292A1 (en) 2000-09-08
EP0941095A1 (en) 1999-09-15
JP2001505910A (ja) 2001-05-08
CZ202599A3 (cs) 1999-09-15
NO325475B1 (no) 2008-05-13
DK0941095T3 (da) 2004-08-02
CA2269682A1 (en) 1998-06-18
DE69728783T2 (de) 2005-03-31
KR20000069360A (ko) 2000-11-25
CA2269682C (en) 2009-04-14
BR9714967A (pt) 2001-10-30
BR9714967B1 (pt) 2010-06-29
CZ297632B6 (cs) 2007-02-14
HUP0000564A2 (hu) 2000-10-28
WO1998025621A1 (en) 1998-06-18
HUP0000564A3 (en) 2001-01-29
PL190662B1 (pl) 2005-12-30
DE69728783D1 (de) 2004-05-27
AU5452998A (en) 1998-07-03
SK72399A3 (en) 2000-05-16
NZ336183A (en) 2000-12-22
EP0941095B1 (en) 2004-04-21
KR100544248B1 (ko) 2006-01-23
CN1238690A (zh) 1999-12-15
US5736151A (en) 1998-04-07
NO992780D0 (no) 1999-06-08

Similar Documents

Publication Publication Date Title
DK0941095T3 (da) Forbedrede farmaceutiske sammensætninger
IL149163A0 (en) Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
NZ505163A (en) Sustained release medicinal compositions comprising an ionic compound with an opposite charge to the ionic active substance
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
FR2743562B1 (fr) Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
FR2754258B1 (fr) Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
ATE235472T1 (de) N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepi - 3-yl)-3-amide
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
IT1277663B1 (it) Sospensioni acquose stabili di mesalazina per uso topico
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
DE69627344D1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
AU1998995A (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
EA200201024A1 (ru) Фармацевтические композиции, содержащие олигосахариды, и их получение
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
FR2707496B1 (fr) Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes.
NO20010624D0 (no) N-substituerte azacykloheptanderivater, fremstilling og anvendelse derav
SE9902147D0 (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma